Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amag Pharmaceuticals (NQ: AMAG )

13.75 USD UNCHANGED
Last Price Updated: 4:06 PM EST, Nov 13, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amag Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
This Drug Approval Is In Jeopardy — So Why Is The Biotech Stock Rising?
Shares of biotech company Amag Pharmaceuticals jumped Monday ahead of a Food and Drug Administration panel to discuss its drug, Makena. Makena is used to prevent premature birth. 
From Investor's Business Daily
51 Biggest Movers From Friday
Gainers Xunlei Ltd (NASDAQ: XNET) shares jumped 107.8% to close at $4.82 on Friday. Anika Therapeutics, Inc. (NASDAQ: ANIK) ... 
Tags VNTR CRVS BUD
From Benzinga
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Earnings, clinical trial readouts and positive FDA verdicts catalyzed fairly robust performances by biotech stocks last week. Biogen ... 
Tags XBI AMGN Biotech
From Benzinga
Noteworthy Friday Option Activity: TAP, AMAG, RP
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Molson Coors Brewing Co. (TAP), where a total of 9,575 contracts have traded so far,... 
Tags Stocks
From Market News Video
AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology
From GlobeNewswire News Releases
Notable Friday Option Activity: ANET, LYFT, AMAG
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Arista Networks Inc (ANET), where a total volume of 2,488 contracts has been traded... 
Tags Stocks
From Market News Video
AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi™ (Bremelanotide Injection) Data in Obstetrics & Gynecology
The RECONNECT Studies Demonstrated a Clinically Meaningful and Statistically Significant Improvement in the Co-Primary Endpoints of Desire and Associated Distress 
From GlobeNewswire News Releases
UPDATE 2-Amag settles with activist Caligan, adds two board directors
Amag Pharmaceuticals Inc, whose shares have tumbled more than 45% in the past year, on Tuesday agreed to add two directors proposed by Caligan Partners after the hedge fund pressured the drugmaker to... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Amag appoints activist investor Caligan's nominees to board
Amag Pharmaceuticals Inc said on Tuesday it settled with activist investor Caligan Partners LP and appointed two of the hedge fund's nominees to its board. 
Tags companyNews
From Reuters: Company News
Amag appoints activist investor Caligan's nominees to board
Amag Pharmaceuticals Inc said on Tuesday it settled with activist investor Caligan Partners LP and appointed two of the hedge fund's nominees to its board. 
Tags companyNews
From Reuters: Company News
AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
Paul Fonteyne and David Johnson Join Board of Directors 
From GlobeNewswire News Releases
Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates
September turned out to be a fruitful month for FDA approvals. The regulatory agency gave its nod to Ardelyx Inc (NASDAQ: ARDX)'s ... 
Tags FOMX Benzinga News
From Benzinga
Caligan Partners Issues Letter to AMAG Shareholders
Caligan Partners LP (“Caligan”), one of the largest shareholders of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) (“AMAG” or the “Company”), today issued a letter to AMAG shareholders in connection with... 
From Business Wire News Releases
AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
From GlobeNewswire News Releases
10.8% Return Seen to Date on SmarTrend Amag Pharmaceuti Call (AMAG)
SmarTrend identified an Uptrend for Amag Pharmaceuti (NASDAQ:AMAG) on August 12th, 2019 at $11.26. In approximately 1 month, Amag Pharmaceuti has returned 10.80% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders
From GlobeNewswire News Releases
45 Biggest Movers From Friday
Gainers McDermott International, Inc. (NYSE: MDR) gained 27.2% to close at $2.01 on Friday after the company announced it will ... 
Tags USAT TTM SJT
From Benzinga
36 Stocks Moving In Friday's Mid-Day Session
Gainers McDermott International, Inc. (NYSE: MDR) jumped 66% to $2.62 after the company announced it will explore strategic ... 
Tags Trading Ideas BW PCG
From Benzinga
UPDATE 2-Camber Capital to discuss Amag's board composition with shareholders
Camber Capital Management on Friday unveiled a stake of about 13% in Amag Pharmaceuticals Inc and said it intends to discuss the drugmaker's board composition with shareholders, weeks after an activist... 
Tags companyNews
From Reuters: Company News
UPDATE 1-Camber Capital to discuss Amag's board composition with shareholders
Camber Capital Management on Friday reported a stake of about 13% in Amag Pharmaceuticals Inc and said it intends to discuss the composition of the drugmaker's board with shareholders, weeks after... 
Tags companyNews
From Reuters: Company News
Camber Capital says Amag Pharma's shares undervalued, seeks changes
Camber Capital Management said on Friday the shares of Amag Pharmaceuticals Inc were undervalued and that it intends to discuss the composition of the company's board of directors with other... 
Tags companyNews
From Reuters: Company News
Amag Pharmaceuti Crosses Above its 10-day MA (AMAG)
Amag Pharmaceuti (NASDAQ:AMAG) shares have crossed bullishly above their 10-day moving average of $12.18 on a volume of 180K shares. Swing traders may find an opportunity for a long... 
From Comtex SmarTrend® News Briefs
Interesting AMAG Put And Call Options For January 2022
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options become available this week, for the January 2022 expiration.. 
Tags Stocks
From Market News Video
Caligan Partners Launches Consent Solicitation Process and Sends Letter to AMAG Shareholders
Caligan Partners LP (“Caligan”), one of the largest shareholders of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”), announced today that it has mailed a letter to AMAG shareholders... 
From Business Wire News Releases
AMAG Sends Letter to Shareholders
Urges Shareholders Take No Action On Caligan Consent Solicitation 
From GlobeNewswire News Releases
Interesting AMAG Put And Call Options For December 20th
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options begin trading today, for the December 20th expiration.. 
Tags Stocks
From Market News Video
AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
From GlobeNewswire News Releases
AMAG Urges Stockholders to Take No Action on Caligan Partners’ Consent Solicitation Materials
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi™ (Bremelanotide Injection)
From GlobeNewswire News Releases
AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.